Middle segment pancreatectomy in treatment for benign pancreatic tumors and its effect on pancreatic exocrine function
10.3760/cma.j.issn.1674-6090.2016.03.004
- VernacularTitle:中段胰腺切除术治疗胰颈体良性肿瘤对胰腺外分泌功能的影响
- Author:
Defang ZHAO
;
Tong ZHANG
- Publication Type:Journal Article
- Keywords:
Middle segment pancreatectomy;
Benign pancreatic tumors;
Pancreatic exocrine function
- From:
Chinese Journal of Endocrine Surgery
2016;10(3):189-191,211
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the application of middle segment pancreatectomy (MSP) in treating benign pancreatic tumors and the effect on exocrine function.Methods From Jan.2010 to Feb.2013,19 cases with benign pancreatic tumor undergoing MSP were enrolled in our study.Pre-and postoperative pancreatic exocrine function were studied.Results No perioperative death happened.The tumor diameter was 4.2 to 7.0cm,operative time was 80 to 320 mins,and intraoperative blood loss was 200 to 1000 ml.The retained pancreas was＞l.5 cm at pancreatic head side,and＞5 cm at pancreatic caudal side.Three days after surgery,the peritoneal drainage and amylase was 2.5-12.5 ml and 568.4-1013 IU/L,respectively.Seven days after surgery,the peritoneal drainage and amylase was 1.0-19.8 ml and 45.4-76.3 IU/L,respectively.The postoperative hospitalization stay were 10 to 25 days.Three cases (all single anastomosis) had pancreatic fistula after surgery and healed after 3 months without undergoing surgery again.Patients were followed up for 2 months to 3 years.All patients have a good life quality,without new-onset diabetes and cancer recurrence.MSP had no side effects on pancreatic exocrine function.Conclusion MSP is safe and feasible in treatment of benign pancreatic tumors.
